申请人:Takeda Pharmaceutical Company Limited
公开号:EP1997488A1
公开(公告)日:2008-12-03
The present invention provides a prophylactic or therapeutic agent for irritable bowel syndrome, which comprises a compound represented by formula (I):
wherein, R1 represents an optionally substituted hydrocarbon group, etc., R2 represents a hydrogen atom or an optionally substituted hydrocarbon group, R3 represents a hydrogen atom, an optionally substituted hydrocarbon group, etc., X represents CHR4, NR4, CO, O or S (wherein, R4 represents a hydrogen atom, an optionally substituted hydrocarbon group, etc.),Y represents C, CH or N, represents a single bond or double bond, ring A represents an optionally substituted 5- to 7-membered oxygen-containing heterocyclic ring, ring B represents an optionally substituted benzene ring, and m represents an integer of 1 to 4, or a salt thereof.
本发明提供了一种肠易激综合征的预防或治疗剂,它由式 (I) 所代表的化合物组成:
其中,R1 代表任选取代的烃基等,R2 代表氢原子或任选取代的烃基,R3 代表氢原子、任选取代的烃基等、X 代表 CHR4、NR4、CO、O 或 S(其中,R4 代表氢原子、任选取代的烃基等),Y 代表 C、CH 或 N,代表单键或双键,环 A 代表任选取代的 5 至 7 元含氧杂环,环 B 代表任选取代的苯环,m 代表 1 至 4 的整数,或其盐。